These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 38289338)
1. Coupling of Slack and Na Yuan T; Wang Y; Jin Y; Yang H; Xu S; Zhang H; Chen Q; Li N; Ma X; Song H; Peng C; Geng Z; Dong J; Duan G; Sun Q; Yang Y; Yang F; Huang Z Elife; 2024 Jan; 12():. PubMed ID: 38289338 [TBL] [Abstract][Full Text] [Related]
2. New use for an old drug: quinidine in KCNT1-related epilepsy therapy. Liu R; Sun L; Wang Y; Wang Q; Wu J Neurol Sci; 2023 Apr; 44(4):1201-1206. PubMed ID: 36437393 [TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies. M Qunies A; A Emmitte K Pharm Pat Anal; 2022 Mar; 11(2):45-56. PubMed ID: 35369761 [TBL] [Abstract][Full Text] [Related]
13. Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the Kcnt1 gene encoding Slack (K Quraishi IH; Mercier MR; McClure H; Couture RL; Schwartz ML; Lukowski R; Ruth P; Kaczmarek LK Sci Rep; 2020 Feb; 10(1):3213. PubMed ID: 32081855 [TBL] [Abstract][Full Text] [Related]
14. An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack K Quraishi IH; Stern S; Mangan KP; Zhang Y; Ali SR; Mercier MR; Marchetto MC; McLachlan MJ; Jones EM; Gage FH; Kaczmarek LK J Neurosci; 2019 Sep; 39(37):7438-7449. PubMed ID: 31350261 [TBL] [Abstract][Full Text] [Related]
15. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report. Takase C; Shirai K; Matsumura Y; Watanabe T; Watanabe A; Hirasawa-Inoue A; Mizuguchi T; Matsumoto N; Sugai K; Hayashi M Brain Dev; 2020 Sep; 42(8):607-611. PubMed ID: 32505479 [TBL] [Abstract][Full Text] [Related]
16. Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature. Abdelnour E; Gallentine W; McDonald M; Sachdev M; Jiang YH; Mikati MA Seizure; 2018 Feb; 55():1-3. PubMed ID: 29291456 [TBL] [Abstract][Full Text] [Related]
17. The Phe932Ile mutation in KCNT1 channels associated with severe epilepsy, delayed myelination and leukoencephalopathy produces a loss-of-function channel phenotype. Evely KM; Pryce KD; Bhattacharjee A Neuroscience; 2017 May; 351():65-70. PubMed ID: 28366665 [TBL] [Abstract][Full Text] [Related]
18. The Functional Properties, Physiological Roles, Channelopathy and Pharmacological Characteristics of the Slack (KCNT1) Channel. Zhang Q; Liu Y; Xu J; Teng Y; Zhang Z Adv Exp Med Biol; 2021; 1349():387-400. PubMed ID: 35138624 [TBL] [Abstract][Full Text] [Related]
19. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine. Milligan CJ; Li M; Gazina EV; Heron SE; Nair U; Trager C; Reid CA; Venkat A; Younkin DP; Dlugos DJ; Petrovski S; Goldstein DB; Dibbens LM; Scheffer IE; Berkovic SF; Petrou S Ann Neurol; 2014 Apr; 75(4):581-90. PubMed ID: 24591078 [TBL] [Abstract][Full Text] [Related]
20. NBI-921352, a first-in-class, Na Johnson JP; Focken T; Khakh K; Tari PK; Dube C; Goodchild SJ; Andrez JC; Bankar G; Bogucki D; Burford K; Chang E; Chowdhury S; Dean R; de Boer G; Decker S; Dehnhardt C; Feng M; Gong W; Grimwood M; Hasan A; Hussainkhel A; Jia Q; Lee S; Li J; Lin S; Lindgren A; Lofstrand V; Mezeyova J; Namdari R; Nelkenbrecher K; Shuart NG; Sojo L; Sun S; Taron M; Waldbrook M; Weeratunge D; Wesolowski S; Williams A; Wilson M; Xie Z; Yoo R; Young C; Zenova A; Zhang W; Cutts AJ; Sherrington RP; Pimstone SN; Winquist R; Cohen CJ; Empfield JR Elife; 2022 Mar; 11():. PubMed ID: 35234610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]